RecruitingPHASE1, PHASE2NCT06841042

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

Studying Autosomal systemic lupus erythematosus

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sinocelltech Ltd.
Intervention: SCTB35 injection(biological)
Enrollment: 168 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2025 – 2028

Study locations (14)

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
Xuanwu Hospital, Capital Medical University, Beijing, China
Jilin Provincial People's Hospital, Changchun, China
Guangdong Provincial People's Hospital, Guangzhou, China
Zhejiang Provincial People's Hospital, Hangzhou, China
The First People's Hospital of Jiujiang City, Jiujiang, China
The First Affiliated Hospital of Kunming Medical University, Kunming, China
Linfen Central Hospital, Linfen, China
Mianyang Central Hospital, Mianyang, China
The First Affiliated Hospital of Nanchang University, Nanchang, China
Pingxiang People's Hospital, Pingxiang, China
Shanxi Bethune Hospital, Taiyuan, China
The First Affiliated Hospital of Xiamen University, Xiamen, China
Xinxiang Central Hospital, Xinxiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06841042 on ClinicalTrials.gov

Other trials for Autosomal systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Autosomal systemic lupus erythematosus →

← Back to all trials